throbber
242
`
`CHAPTER 17
`
`Example 2-What is the change of pH on adding 0.1 mol ofNaOH to
`1 L of buffer solution 0.1 Min acetic acid and 0.1 Min sodium acetate?
`
`DETERMINATION OF PH
`
`(a) The pH of the buffer solution before adding NaOH is
`
`Colorimetry
`
`A relatively simple and inexpensive method for determining
`the approximate pH of a solution depends on the fact that some
`conjugate acid-base pairs (indicators) possess one color in the
`acid form and another color in the base form. Assume that the
`acid form of a particular indicator is red, and the base form is
`yellow. The color of a solution of this indicator will range from
`red when it is sufficiently acid, to yellow when it is sufficiently
`alkaline.
`In the intermediate pH range (the transition interval) the
`color will be a blend of red and yellow depending upon the ratio
`of the base to the acid form. In general, although there are
`slight differences between indicators, color changes apparent to
`the eye cannot be discerned when the ratio of base to acid form,
`or acid to base form exceeds 10:1. The use of Equation 83
`indicates that the transition range of most indicators is equal to
`the pKa of the indicator ± 1 pH unit, or a useful range of
`approximately two pH units. Standard indicator solutions can
`be made at known pH values within the transition range of the
`indicator, and the pH of an unknown solution can be deter(cid:173)
`mined by adding the indicator to it and comparing the resulting
`color with the standard solutions.
`Another method for using these indicators is to apply them
`to thin strips of filter paper. A drop of the unknown solution is
`placed on a piece of the indicator paper and the resulting color
`is compared to a color chart supplied with the indicator paper.
`These papers are available in a wide variety of pH ranges.
`
`Potentiometry
`
`Electrometric methods for the determination of pH are based
`on the fact that the difference of electrical potential between
`two suitable electrodes dipping into a solution containing hy(cid:173)
`dronium ions depends on the concentration (or activity) of the
`latter. The development of a potential difference is not a spe(cid:173)
`cific property of hydronium ions. A solution of any ion will
`develop a potential proportional to the concentration of that ion
`if a suitable pair of electrodes is placed in the solution.
`The relationship between the potential difference and con(cid:173)
`centration of an ion in equilibrium with the electrodes may be
`derived as follows. When a metal is immersed into a solution of
`one of its salts, there is a tendency for the metal to go into
`solution in the form of ions. This tendency is known as the
`solution pressure of the metal and is comparable to the ten(cid:173)
`dency of sugar molecules (eg, to dissolve in water). The metallic
`ions in solution tend, on the other hand, to become discharged
`by forming atoms, this effect being proportional to the osmotic
`pressure of the ions.
`For an atom of a metal to go into solution as a positive ion,
`electrons, equal in number to the charge on the ion, must be left
`behind on the metal electrode with the result that the latter
`becomes negatively charged. The positively charged ions in
`solution, however, may become discharged as atoms by taking
`up electrons from the metal electrode. Depending on which
`effect predominates, the electrical charge on the electrode will
`be either positive or negative and may be expressed quantita(cid:173)
`tively by the following equation proposed by Nernst in 1889:
`
`RT p
`E=nFlnP
`
`(84)
`
`where E is the potential difference or electromotive force, R is
`the gas constant (8.316 joules), Tis the absolute temperature,
`n is the valence of the ion, Fis the Faraday of electricity (96,500
`
`[base]
`pH = log [acid] + pKa
`
`0.1
`=logo.I+ 4.76 = 4.76
`
`(b) On adding 0.01 mo! ofNaOH per liter to this buffer solution, 0.01
`mol of acetic acid is converted to 0.01 mol of sodium acetate, thereby
`decreasing the concentration of acid to 0.09 M and increasing the
`concentration of base to 0.11 M . The pH is calculated as
`
`0.1 l
`9 + 4.76
`0
`= 0.087 + 4.76 = 4.85
`
`_0
`
`pH= log
`
`The change of pH in this case is only 0.09 unit, about 1/10 the change
`in the preceding example. The buffer capacity is calculated as
`
`mols of NaOH added
`change of pH
`
`0.0 l
`= 0.09 = O. ll
`
`Thus, the buffer capacity of the acetic acid-sodium acetate buffer solu(cid:173)
`tion is approximately 10 times that of the acetic acid solution.
`
`As is in part evident from these examples, and may be
`further evidenced by calculations of pH changes in other sys(cid:173)
`tems, the degree of buffer action and, therefore, the buffer
`capacity, depend on the kind and concentration of the buffer
`components, the pH region involved and the kind of acid or
`alkali added.
`STRONG ACIDS AND BASES AS "BUFFERS"-In the
`foregoing discussion, buffer action was attributed to systems of
`(1) weak acids and their conjugate bases, (2) weak bases and
`their conjugate acids, and (3) certain acid-base pairs that can
`function in the manner either of system 1 or 2.
`The ability to resist change in pH on adding acid or alkali is
`possessed also by relatively concentrated solutions of strong
`acids and strong bases. If to 1 L of pure water having a pH of
`7 is added 1 mL of 0.01 M hydrochloric acid, the pH is reduced
`to about 5. If the same volume of the acid is added to 1 L of
`0.001 M hydrochloric acid, which has a pH of about 3, the
`hydronium-ion concentration is increased only about 1 % and
`the pH is reduced hardly at all. The nature of this buffer action
`is quite different from that of the true buffer solutions. The
`very simple explanation is that when 1 mL of 0.01 M HCl,
`which represents 0.00001 g-eq of hydronium ions, is added to
`the 0.0000001 g-eq ofhydronium ions in 1 L of pure water, the
`hydronium-ion concentration is increased 100-fold (equivalent
`to two pH units), but when the same amount is added to the
`0.001 g-eq of hydronium ions in 1 L of 0.001 M HCl, the
`increase is only 1/100 the concentration already present.
`Similarly, if 1 mL of0.01 M NaOH is added to 1 L of pure wa(cid:173)
`ter, the pH is increased to 9, while if the same volume is added
`to 1 L of 0.001 molar NaOH, the pH is increased al(cid:173)
`most immeasurably.
`In general, solutions of strong acids of pH 3 or less, and
`solutions of strong bases of pH 11 or more, exhibit this kind of
`buffer action by virtue of the relatively high concentration of
`hydronium or hydroxyl ions present. The USP includes among
`its Standard Buffer Solutions a series of hydrochloric acid
`buffers, covering the pH range 1.2 to 2.2, which also contain
`potassium chloride. The salt does not participate in the buffer(cid:173)
`ing mechanism, as is the case with salts of weak acids; instead,
`it serves as a nonreactive constituent required to maintain the
`proper electrolyte environment of the solutions.
`
`Slayback Exhibit 1101, Page 21 of 39
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`IONIC SOLUTIONS AND ELECTROLYTIC EQUILIBRIA
`
`RT
`I
`£ a. -
`ln(cid:173)
`nF
`c1
`
`or in terms of Briggsian logarithms
`
`I
`RT
`E = 2.30:3 nFlog, 0 -
`c'2
`
`243
`
`(88)
`
`(89)
`
`If for log10 1/c:! there is substituted its equivalent pH, the
`equation becomes
`
`RT
`E = 2.:30:3 nF pH
`
`(90)
`
`and finally by substituting numerical values for R, n, T, and F,
`and assuming the temperature to be 20°, the following simple
`relationship is derived:
`
`(91)
`
`E
`581
`
`_0
`
`0
`
`E = 0.0581 pH or pH=
`
`The hydrogen electrode dipping into a solution of known
`hydronium-ion concentration, called the reference electrode,
`may be replaced by a calomel electrode, one type of which is
`shown in Figure 17-4. The elements of a calomel electrode are
`mercury and calomel in an aqueous solution of potassium chlo(cid:173)
`ride. The potential of this electrode is constant, regardless of
`the hydronium-ion concentration of the solution into which it
`dips . The potential depends on the equilibrium that is set up
`between mercury and mercurous ions from the calomel, but
`the concentration of the latter is governed, according to the
`solubility-product principle. by the concentration of chloride
`ions, which are derived mainly from the potassium chloride in
`the solution. Therefore. the potential of this electrode varies
`with the concentration of potassium chloride in the electrolyte.
`Because the calomel electrode always indicates voltages
`that are higher, by a constant value. than those obtained when
`the normal hydrogen electrode chain shown in Figure 17-3 is
`used, it is necessary to subtract the potential due to the calomel
`electrode itself from the observed voltage. As the magnitude of
`this voltage depends on the concentration of potassium chloride
`in the calomel-electrode electrolyte, it is necessary to know the
`concentration of the former. For most purposes a saturated
`potassium chloride solution is used that produces potential
`
`+
`
`t·t;•f:C~•\:~i?~
`::~f{.:~\:~:_r~~~-
`
`-•, • •:. , , • . • , ~
`
`SOLUTION
`
`CALOMEL
`
`PURE MERCLRY
`
`Pt.A TN..t,A WIRE
`
`ORDINARY t,EROR,<
`
`Figure 17-4. Calomel electrode.
`
`p
`
`=il-1=-
`
`A
`
`------
`Figure 17-3. Hydrogen-ion concentration chain.
`
`8 =-=
`
`coulombs >. p is the osmotic pressure of the ions. and P is the
`solution pressure of the metal.
`Inasmuch as it is impossible to measure the potential dif(cid:173)
`ference between one electrode and a solution with any degree of
`certainty, it is customary to use two electrodes and to measure
`the potential difference between them. If two electrodes. both of
`the same metal. are immersed in separate solutions containing
`ions of that metal-at osmotic pressure p 1 and P:!, respectively
`-and are connected by means of a tube containing a nonreact(cid:173)
`ing salt solution (a so-called salt bridge). the potential devel(cid:173)
`oped across the two electrodes will be equal to the difference
`between the potential differences of the individual electrodes:
`thus.
`
`p , RT p.,
`RT
`E = E , - E-, = -
`In -
`-
`-
`In _.:c
`nF P ,
`nF P~
`-
`
`(85)
`
`As both electrodes are of the same metal, P 1
`equation may be simplified to
`
`P:! and the
`
`RT
`E ~ -
`In µ 1 -
`nF
`
`RT P ,
`RT
`In p ~ "" -
`In -:--
`-
`-n.F
`nF
`JJ ~
`
`(86)
`
`In place of osmotic pressures it is permissible, for dilute
`solutions, to substitute the concentrations c 1 and c'.! that were
`found (see Chapter 16). to be proportional to p 1 and p 2 • The
`equation then becomes
`
`RT
`E = -In (cid:173)
`nF
`-
`
`c,
`c~
`
`187 1
`
`If either c 1 or c:2 is known, it is obvious that the value of the
`other may be found if the potential difference. E. of this cell can
`be measured.
`For the determination of hydronium-ion concentration or
`pH. an electrode at which an equilibrium between hydrogen
`gas and hydronium ion can be established must be used in
`place of metallic electrodes. Such an electrode may be made by
`electrolytically coating a strip of platinum, or other noble
`metal, with platinum black and saturating the latter with
`pure hydrogen gas. This device functions as a hydrogen elec(cid:173)
`trode. Two such electrodes may be assembled as shown in
`Figure 17-3.
`In this diagram one electrode dips into Solution A, contain(cid:173)
`ing a known hydronium-ion concentration, and the other elec(cid:173)
`trode dips into Solution B, containing an unknown hydronium(cid:173)
`ion concentration. The two electrodes and solutions. sometimes
`called half-cells, then are connected by a bridge of neutral salt
`solution, which has no significant effect on the solutions it
`connects. The potential difference across the two electrodes is
`measured by means of a potentiometer, P. If the concentra(cid:173)
`tion, c1, of hydronium ion in Solution A is 1 N, Equation 87
`simplifies to
`
`Slayback Exhibit 1101, Page 22 of 39
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`244
`
`CHAPTER 17
`
`difference of 0.2488 V. Accordingly, before using Equation 86
`for the calculation of pH from the voltage of a cell made up of a
`calomel and a hydrogen electrode dipping into the solution to
`be tested, 0.2488 V must be subtracted from the observed
`potential difference. Expressed mathematically, Equation 92 is
`used for calculating pH from the potential difference of such a
`cell.
`
`ments available permit reading the pH directly and provide
`also for compensation of variations due to temperature in the
`range of 0° to 50° and to the small but variable asymmetry
`potential inherent in the glass electrode.
`
`E - 0.2488
`pH=
`0.0581
`
`PHARMACEUTICAL SIGNIFICANCE
`
`(92)
`
`•
`
`•
`
`In measuring the potential difference between the elec(cid:173)
`trodes, it is imperative that very little current be drawn from
`the cell, for with current flowing the voltage changes, owing to
`polarization effects at the electrode. Because of this it is not
`possible to make accurate measurements with a voltmeter that
`requires appreciable current to operate it. In its place a poten(cid:173)
`tiometer is used that does not draw a current from the cell
`being measured.
`There are many limitations to the use of the hydrogen
`electrode:
`It cannot be used in solutions containing strong oxidants such as
`•
`ferric iron, dichromates, nitric acid, peroxide, or chlorine or reduc(cid:173)
`tants such as sulfurous acid and hydrogen sulfide.
`It is affected by the presence of organic compounds that are reduced
`fairly easily.
`It cannot be used successfully in solutions containing cations that
`fall below hydrogen in the electrochemical series.
`• Erratic results are obtained in the measurement of unbuffered
`solutions unless special precautions are taken.
`It is troublesome to prepare and maintain.
`•
`As other electrodes more convenient to use now are available,
`the hydrogen electrode today is used rarely. Nevertheless, it is
`the ultimate standard for pH measurements.
`To avoid some of the difficulties with the hydrogen electrode,
`the quinhydrone electrode was introduced and was popular for
`a long time, particularly for measurements of acid solutions.
`The unusual feature of this electrode is that it consists of a
`piece of gold or platinum wire or foil dipping into the solution to
`be tested, in which has been dissolved a small quantity of
`quinhydrone. A calomel electrode may be used for reference,
`just as in determinations with the hydrogen electrode.
`Quinhydrone consists of an equimolecular mixture of qui(cid:173)
`none and hydroquinone; the relationship between these sub(cid:173)
`stances and hydrogen-ion concentration is
`
`Quinone + 2 Hydrogen ions + 2 Electrons ;:= Hydroquinone
`
`In a solution containing hydrogen ions the potential of the
`quinhydrone electrode is related logarithmically to hydronium(cid:173)
`ion concentration if the ratio of the hydroquinone concentration
`to that of quinone is constant and practically equal to l. This
`ratio is maintained in an acid solution containing an excess of
`quinhydrone, and measurements may be made quickly and
`accurately; however, quinhydrone cannot be used in solutions
`more alkaline than pH 8.
`An electrode that, because of its simplicity of operation and
`freedom from contamination or change of the solution being
`tested, has replaced both the hydrogen and quinhydrone elec(cid:173)
`trodes is the glass electrode. It functions because when a thin
`membrane of a special composition of glass separates two so(cid:173)
`lutions of different pH, a potential difference develops across
`the membrane that depends on the pH of both solutions. If the
`pH of one of the solutions is known, the other may be calculated
`from the potential difference.
`In practice, the glass electrode usually consists of a bulb of
`the special glass fused to the end of a tube of ordinary glass.
`Inside the bulb is placed a solution of known pH, in contact
`with an internal silver-silver chloride or other electrode. This
`glass electrode and another reference electrode are immersed
`in the solution to be tested and the potential difference is
`measured. A potentiometer providing electronic amplification
`of the small current produced is employed. The modern instru-
`
`In the broad realm of knowledge concerning the preparation
`and action of drugs few, if any, variables are so important as
`pH. For the purpose of this presentation, four principal types of
`pH-dependence of drug systems will be discussed: solubility,
`stability, activity, and absorption.
`
`Drug Solubility
`
`If a salt, NaA, is added to water to give a concentration c., the
`following reactions occur:
`
`If the pH of the solution is lowered, more of the A- would be
`converted to the unionized acid, HA, in accordance with Le
`Chatelier's principle. Eventually, a pH will be obtained, below
`which the amount of HA formed exceeds its aqueous solubility,
`S0 , and the acid will precipitate from solution; this pH can be
`designated as pH.P. At this point, at which the amount of HA
`formed just equals S0 , a mass balance on the total amount of
`drug in solution yields
`
`(93)
`
`Replacing [A-J as a function of hydronium-ion concentration
`gives
`
`C, = So + [H o+ I + K
`a
`3
`
`p
`
`( 94 )
`
`where K0 is the ionization constant for the conjugate acid, HA,
`and [H30+]P refers to the hydronium-ion concentration above
`which precipitation will occur. This equation can be rearranged
`to give
`
`Taking logarithms gives
`
`(95)
`
`(96)
`
`Thus, the pH below which precipitation occurs is a function of
`the amount of salt added initially, the pK0 and the solubility of
`the free acid formed from the salt.
`The analogous equation for salts of weak bases and strong
`acids (such as pilocarpine hydrochloride, cocaine hydrochlo(cid:173)
`ride, or codeine phosphate) would be
`
`So
`pH!> = pKa + log C., _ So
`
`(97 )
`
`in which pK0 refers to the protonated form of the weak base.
`Example-Below what pH will free phenobarbital begin to precipi(cid:173)
`tate from a solution initially containing 1.3 g of sodium phenobarbital/
`100 mL at 25°? The molar solubility of phenobarbital is 0.0050 and its
`pK0 is 7.41. The molecular weight of sodium phenobarbital is 254.
`The molar concentration of salt initially added is
`
`Slayback Exhibit 1101, Page 23 of 39
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`_
`1:3
`g/ L
`C, = mol wt= 254 = 0.0;,I M
`
`ing specific emulsion systems, and the effect of pH upon them,
`may be found in Chapter 21.
`
`IONIC SOLUTIONS AND ELECTROLYTIC EQUILIBRIA
`
`245
`
`Drug Activity
`
`Drugs that are weak acids or weak bases-and hence may exist
`in ionized or nonionized form (or a mixture of bothJ-may be
`active in one form but not in the other; often such drugs have an
`optimum pH range for maximum activity. Thus, mandelic acid,
`benzoic acid, or salicylic acid have pronounced antibacterial
`activity in nonionized form but have practically no such activity
`in ionized form. Accordingly, these substances require an acid
`environment to function effectively as antibacterial agents. For
`example, sodium benzoate is effective as a reservative in 4%
`concentration at pH 7, in 0.06 to 0.1% concentration at pH 3.5
`to 4, and in 0.02 to 0.03% concentration at pH 2.3 to 2.4. Other
`antibacterial agents are active principally. if not entirely, in
`cationic form. Included in this category are the acridines and
`quaternary ammonium compounds.
`
`Drug Absorption
`
`The degree of ionization and lipoid solubility of a drug are two
`important factors that determine the rate of absorption of
`drugs from the gastrointestinal tract, and indeed their passage
`through cellular membranes generally. Drugs that are weak
`organic acids or bases, and that in nonionized form are soluble
`in lipids, apparently are absorbed through cellular membranes
`by virtue of the lipoidal nature of the membranes. Completely
`ionized drugs, on the other hand, are absorbed poorly, if at all.
`Rates of absorption of a variety of drugs are related to their
`ionization constants and in many cases may be predicted quan(cid:173)
`titatively on the basis of this relationship. Thus, not only the
`degree of the acidic or basic character of a drug, but also
`consequently the pH of the physiological medium (eg, gastric or
`intestinal fluid, plasma, cerebrospinal fluid) in which a drug is
`dissolved or dispersed- because this pH determines the extent
`to which the drug will be converted to ionic or nonionic form(cid:173)
`become important parameters of drug absorption. Further in(cid:173)
`formation on drug absorption is given in Chapter 58.
`
`REFERENCES
`l. Benet LZ. Goyan JE. J Pharm Sci 1965: 54: 1179.
`2. Riegelman Set al. J Pharm Sci 1962; 51: 129.
`3. Niebergall P,J et al. J Pharm Sci 1972; 61: 232.
`
`BIBLIOGRAPHY
`Conway BE. Ionic Hydration in Chemistry and Biophysics. Amsterdam:
`Elsevier. 1980.
`Denbigh K. The Principles of Chemical Equilibrium, 4th ed. London:
`Cambridge University Press. 1981.
`Freist>r H. Fernando Q. Ionic Equilibria in .4.nalytical Chemistry. New
`York: Wiley. 1966.
`Harned HS, Owen BB. The Physical Chemistry of Electrolytic Solutions.
`New York, Reinhold. 1958.
`
`0.051 - 0.005
`pHr = 7.41 + log
`05
`0
`= 7.41 + o.96 = s.:37
`Example-Above what pH will free cocaine begin to precipitate from
`a solution initially containing 0.0294 mo! of cocaine hydrochloride per
`liter? The pKb of cocaine is 5.59, and its molar solubility is 5.60 ,; 10-:i_
`
`_0
`
`pK., = pK,. - pK,. = 14.00 - 5.59 = 8.4 I
`0.0056
`pH,,= S.4! + log 0.0'.l94 - 0.0056
`= 8.41 + (-0.6:3) = 7.78
`
`Drug Stability
`
`One of the most diversified and fruitful areas of study is the
`investigation of the effect of hydrogen-ion concentration on the
`stability or. in more general terms. the reactivity of pharma(cid:173)
`ceutical systems. The evidence for enhanced stability of sys(cid:173)
`tems when these are maintained within a narrow range of pH,
`as well as of progressively decreasing stability as the pH de(cid:173)
`parts from the optimum range, is abundant. Stability (or in(cid:173)
`stability) of a system may result from gain or loss of a proton
`(hydrogen ion) by a substrate molecule-often accompanied by
`an electronic rearrangement-that reduces (or increases) the
`reactivity of the molecule. Instability results when the sub(cid:173)
`stance desired to remain unchanged is converted to one or more
`other, unwanted. substances. In aqueous solution, instability
`may arise through the catalytic effect of acids or bases-the
`former by transferring a proton to the substrate molecule, the
`latter by accepting a proton.
`Specific illustrations of the effect of hydrogen-ion concentra(cid:173)
`tion on the stability of medicinals are myriad; only a few will be
`given here, these being chosen to show the importance of pH
`adjustment of solutions that require sterilization.
`Morphine solutions are not decomposed during a 60-min
`exposure at a temperature of 100° if the pH is less than 5.5;
`neutral and alkaline solutions, however, are highly unstable.
`Minimum hydrolytic decomposition of solutions of cocaine oc(cid:173)
`curs in the range of pH of 2 to 5; in one study a solution of
`cocaine hydrochloride, initially at a pH of 5.7, remained stable
`during 2 months (although the pH dropped to 4.2 in this timel,
`while another solution buffered to about pH 6 underwent ap(cid:173)
`proximately 30% hydrolysis in the same time. Similarly, solu(cid:173)
`tions of procaine hydrochloride containing some hydrochloric
`acid showed no appreciable decomposition; when dissolved in
`water alone, 5% of the procaine hydrochloride hydrolyzed,
`whereas when buffered to pH 6.5. from 19 to 35% underwent
`decomposition by hydrolysis. Solutions of thiamine hydrochlo(cid:173)
`ride may be sterilized by autoclaving without appreciable de(cid:173)
`composition if the pH is below 5; above this, thiamine hydro(cid:173)
`chloride is unstable.
`The stability of many disperse systems. and especially of
`certain emulsions, is often pH dependent. Information concern-
`
`Slayback Exhibit 1101, Page 24 of 39
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`This material may be protected by Copyright law (Title 17 U.S. Code)
`
`Ophthalmic Preparations
`
`CHAPTER43
`
`Gerald Hecht, PhD
`Senior Director, Pharmaceutical Sciences
`Alcon Laboratories
`Fort Worth, TX 76101
`
`Ophthalmic preparations are sterile products essentially free
`from foreign particles, suitably compounded and packaged for
`instillation into the eye. Ophthalmic preparations include so(cid:173)
`lutions, suspensions, ointments, and solid dosage forms. The
`solutions and suspensions are, for the most part, aqueous.
`Ophthalmic ointments usually contain a white petrolatum(cid:173)
`mineral oil base.
`Ophthalmic preparations can be grouped broadly into two
`divisions of major significance to the pharmacist. These include
`single or multidose prescription products and the category de(cid:173)
`scribed as OTC or over-the-counter ophthalmic products. The
`latter group has been subjected to a searching review and
`analysis by a body of experts as a part of the Food and Drug
`Administration's (FDA) OTC Drug Review process.
`The single dominant factor characteristic of all ophthalmic
`products is the specification of sterility. Any product intended
`for use in the eye regardless of form, substance, or intent must
`be sterile. This requirement increases the similarity between
`ophthalmic and parenteral products; however the physiology
`of the human eye in many respects imposes more rigid
`formulation requirements . This is considered in the following
`discussion.
`Preparations intended for the treatment of eye disorders
`can be traced to antiquity. Egyptian papyri writings describe
`eye medications. The Greeks and Romans expanded such uses
`and gave us the term collyria . Collyria refers collectively to
`materials that were dissolved in water, milk, or egg white for
`use as eyedrops. In the Middle Ages collyria included mydriatic
`substances to dilate the pupils of milady's eyes for cosmetic
`purposes, thus the term belladonna, or beautiful lady.
`From the time of belladonna collyria, ophthalmic technology
`progressed at a pharmaceutical snail's pace well into modern
`times. It was not until after World War II that the concept of
`sterility became mandatory for ophthalmic solutions. Prior to
`World War II and continuing into the 1940s very few ophthal(cid:173)
`mic preparations were available commercially or were de(cid:173)
`scribed officially. The USP XIV, official in 1950, included only
`three ophthalmic preparations, and all three were ointments.
`Preparations to be used in the eye, either solutions or oint(cid:173)
`ments, invariably were compounded in the community or hos(cid:173)
`pital pharmacy and were intended for immediate (prescription)
`use. Such preparation and prompt use is reflected in the phar(cid:173)
`maceutical literature of the times. The stability of ophthalmic
`preparations is discussed in terms of days or a few months.
`One of the most important attributes of ophthalmic products
`is the requirement of sterility. Even that, however, is a sur(cid:173)
`prisingly recent event. The USP XV in 1955 was the first
`official compendium to include a sterility requirement for oph(cid:173)
`thalmic solutions. The FDA in 1953 adopted the position that a
`nonsterile ophthalmic solution was adulterated. Sterile oph(cid:173)
`thalmic products were, of course, available prior to the mid-
`1950s; however the legal requirement of sterility dates only
`from 1955.
`
`The sterility requirements for ophthalmic ointments ap(cid:173)
`peared first in the USP XVIII, Third Supplement (1972). Prior
`to that date there was no legal requirement for a sterile oph(cid:173)
`thalmic ointment. This probably was due to the difficulty (at
`that time) of testing for sterility in such nonaqueous systems
`and also the anticipated difficulties in sterilizing and maintain(cid:173)
`ing sterile conditions during the manufacture and filling of
`ointments on a large scale.
`
`ANATOMY AND PHYSIOLOGY OF THE EYE
`
`The human eye is a challenging subject for topical administra(cid:173)
`tion of drugs. The basis of this can be found in the anatomical
`arrangement of the surface tissues and in the permeability of
`the cornea. The protective operation of the eyelids and lacrimal
`system is such that there is rapid removal of material instilled
`into the eye, unless the material is suitably small in volume
`and chemically and physiologically compatible with surface
`tissues. Figures 43-1 1 and 43-2 1 include pertinent anatomy of
`the human eye.
`EYELIDS-The eyelids serve two purposes: mechanical
`protection of the globe and creation of an optimum milieu for
`the cornea. The eyelids are lubricated and kept fluid-filled by
`secretions of the lacrimal glands and specialized cells residing
`in the bulbar conjunctiva. The antechamber has the shape of a
`narrow cleft directly over the front of the eyeball, with pocket(cid:173)
`like extensions upward and downward. The pockets are called
`the superior and inferior fornices (vaults), and the entire space,
`the cul-de-sac. The elliptical opening between the eyelids is
`called the palpebral fissure.
`EYEBALL-The wall of the human eyeball (bulbus, globe)
`is composed of three concentric layers.
`1. The outer fibrous layer.
`2. A middle vascular layer-the uvea or uveal tract, consisting of the
`choroid, the ciliary body, and the iris.
`3. A nervous layer-the retina.
`The outer layer is tough, pliable, but only slightly stretchable.
`In its front portion-the portion facing the outside world-the
`fine structure of the outer layer is so regular and the water
`content so carefully adjusted that it acts as a clear, transparent
`window (the cornea). It is devoid of blood vessels. Over the
`remaining two-thirds the fibrous coat is opaque (the white of
`the eye) and is called the sclera. It contains the microcircula(cid:173)
`tion, which nourishes the tissues of this anterior segment, and
`is usually white except when irritated and vessel dilatation
`occurs.
`The eyeball houses an optical apparatus that causes in(cid:173)
`verted reduced images of the outside world to form on the
`retina, which is a thin translucent membrane. The optical
`apparatus consists, in sequence, of the precorneal film, the
`cornea, the aqueous humor, the pupil, the crystalline lens, the
`
`821
`
`Slayback Exhibit 1101, Page 25 of 39
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`822
`
`CHAPTER 43
`
`\
`
`'\
`~ •~ co:~::,';t---~.,,
`
`L
`
`¾{;;J
`
`wo~/!%t\ \
`CRYPTS OF b
`
`' ,
`
`6---,,,.,..,+-- LiNz°s OF
`
`MEIBO~~:~E--,--!;!---+,.e,=!Jl
`
`GLAN DS-~ - - - ; ;
`
`TARSAL PLATE-.,;-'!----t
`
`GLAN DS OF
`ZEIS
`(SEBACEOUS)
`
`GLANDS OF MOLL A
`
`(SWEAT)
`
`VITR EOUS
`HUMOR
`
`Figure 43-1. The eye: vertical section .1
`
`vitreous humor, and the retina. The aqueous and vitreous
`humors are layers of clear fluid or gel-like material interposed
`between the solid structures. The pupil, a round centric hole in
`a contractile membranous partition (called the iris), acts as the
`variable aperture of the system. The crystalline lens is a re(cid:173)
`fractive element with variable power controlled and supported
`by a muscle incorporated in the ciliary body. The choroid is the
`metabolic support for the retina.
`The optical function of the eye calls for stability of its di(cid:173)
`mensions, which is provided partly by the fibrous outer coat;
`more effective as a stabilizing factor is the intraocular pres(cid:173)
`sure, which exceeds the pressure prevailing in the surrounding
`tissues. This intraocular pressure is the result of a steady
`production of specific fluid, the aqueous humor, which origi(cid:173)
`nates from the ciliary processes and leaves the eye by an
`intricate system of outflow channels. The resistance encoun(cid:173)
`tered during this passage and the rate of aqueous production
`are the principal factors determining the level of the intraocu(cid:173)
`lar pressure. In addition to this hydromechanical function, the
`aqueous humor acts as a carrier of nutrients, substrates, and
`metabolites for the avascular tissues of the eye.
`The bones of the skull join to form an approximately
`pyramid-shaped housing for the eyeball, called the orbit.
`CONJUNCTIVA-The conjunctiva! membrane covers the
`outer surface of the white portion of the eye and the inner
`aspect of the eyelids. In most places it is attached loosely and
`thus permits free movement of the eyeball. This makes possible
`subconjunctival injections. Except for the cornea the conjunc(cid:173)
`tiva is the most exposed portion of the eye.
`LACRIMAL SYSTEM-The conjunctiva! and corneal sur(cid:173)
`faces are covered and lubricated by a film of fluid secreted by
`the conjunctiva! and lacrimal glands. The secretion of the lac(cid:173)
`rimal gland, the tears, is delivered through a number of fine
`ducts into the conjunctiva! fornix. The s

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket